Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page indicates an updated site revision number (from v3.5.2 to v3.5.3). This reflects a versioning update of the page itself rather than a substantive change to the trial information.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:16.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; the previous v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:31:15.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T09:39:32.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T05:09:42.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The update includes a minor site-version revision (Revision: v3.4.2) and removal of a government-operating-status notice; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T16:29:28.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    A government funding lapse notice was added and the revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:48:12.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.